"Serum Amyloid A Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An ACUTE PHASE REACTION protein present in low concentrations in normal sera, but found at higher concentrations in sera of older persons and in patients with AMYLOIDOSIS. It is the circulating precusor of amyloid A protein, which is found deposited in AA type AMYLOID FIBRILS.
Descriptor ID |
D000685
|
MeSH Number(s) |
D12.776.049.407.750 D12.776.124.050.725
|
Concept/Terms |
Serum Amyloid A Protein- Serum Amyloid A Protein
- Amyloid A Protein-Related Serum Component
- Amyloid A Protein Related Serum Component
- Amyloid Protein AA Precursor
- Serum Amyloid Protein A
- Amyloid Serum Protein SAA
- Amyloid-Related Serum Protein (SAA)
- Serum A Related Protein
- Serum Amyloid A
- Amyloid A Precursor
- Amyloid Protein SAA
|
Below are MeSH descriptors whose meaning is more general than "Serum Amyloid A Protein".
Below are MeSH descriptors whose meaning is more specific than "Serum Amyloid A Protein".
This graph shows the total number of publications written about "Serum Amyloid A Protein" by people in this website by year, and whether "Serum Amyloid A Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 1 | 1 | 2 |
2006 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Serum Amyloid A Protein" by people in Profiles.
-
Association of subclinical inflammation with deterioration of glycaemia before the diagnosis of type 2 diabetes: the KORA S4/F4 study. Diabetologia. 2015 Oct; 58(10):2269-77.
-
Acute-phase serum amyloid A protein and its implication in the development of type 2 diabetes in the KORA S4/F4 study. Diabetes Care. 2013 May; 36(5):1321-6.
-
Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention Study. Diabetes. 2006 Aug; 55(8):2340-6.
-
Increased atherosclerotic lesion area in apoE deficient mice overexpressing bovine growth hormone. Atherosclerosis. 2006 Oct; 188(2):331-40.
-
Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis. 2006 Jan; 184(1):216-24.